Literature DB >> 32583310

Apelin, Omentin-1, and Vaspin in patients with essential hypertension: association of adipokines with trace elements, inflammatory cytokines, and oxidative damage markers.

Fatma Behice Serinkan Cinemre1, Hakan Cinemre2, Nurten Bahtiyar3, Behlül Kahyaoğlu4, Mustafa Tarık Ağaç4, Harika Shundo5, Leyla Sevinç6, Birsen Aydemir7.   

Abstract

BACKGROUND: Hypertension (HT) is a disease associated with endothelial dysfunction which is related to some adipokines and pro- and anti-inflammatory cytokines. AIMS: Our aim was to investigate roles of apelin, omentin-1, and vaspin in essential HT and to evaluate their relationships with other pro- and anti-inflammatory cytokines, trace elements, and oxidative stress. We also investigated these parameters to determine asymptomatic target organ damage period and grading essential hypertension.
METHODS: One hundred fifty-three patients diagnosed with essential hypertension and 45 healthy controls were included in the study. Hypertension was defined as a systolic blood pressure > 140 mmHg and/or a diastolic blood pressure > 90 mm Hg or current use of an antihypertensive medication. The patients who had secondary HT, other chronic metabolic, cardiovascular, cerebrovascular diseases were excluded. History and physical exam including detailed cardiovascular examination were performed in all participants. Adipokines, cytokines, trace elements, lipid peroxidation, and ischemia-modified albumin levels were measured in blood samples by biochemical methods.
RESULTS: Vaspin, IL-4, IL-8, IL-10, selenium, and zinc levels were significantly lower in the HT group compared to healthy controls while omentin-1, TNF-α, copper, iron, MDA, SOD, and IMA-C levels were significantly higher in HT patients compared to controls. Multiple ordinal regression revealed that TNF-α, IL-10, and body mass index of patients were statistically significant independent predictors (P = 0.024, P = 0.019, and P = 0.032, respectively) for grading of HT. IL-4 and IL-10 were significantly higher in patients with asymptomatic target organ damage, compared to patients without asymptomatic target organ damage (P = 0.032 and P = 0.015, respectively). Our findings suggest that adipokines apelin, omentin, and vaspin may be involved in hypertension by a complex interaction with the anti- and pro-inflammatory cytokines, trace elements, and oxidative stress pathways.

Entities:  

Keywords:  Apelin; Hypertension; Inflammation; Omentin; Oxidative stress; Trace elements; Vaspin

Mesh:

Substances:

Year:  2020        PMID: 32583310     DOI: 10.1007/s11845-020-02272-w

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  49 in total

Review 1.  Essential hypertension. Part I: definition and etiology.

Authors:  O A Carretero; S Oparil
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

Review 2.  Adiponectin--a key adipokine in the metabolic syndrome.

Authors:  J P Whitehead; A A Richards; I J Hickman; G A Macdonald; J B Prins
Journal:  Diabetes Obes Metab       Date:  2006-05       Impact factor: 6.577

Review 3.  Secretory function of adipose tissue.

Authors:  J Kuryszko; P Sławuta; G Sapikowski
Journal:  Pol J Vet Sci       Date:  2016       Impact factor: 0.821

4.  Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.

Authors:  Stephanie Madec; Massimo Chiarugi; Eleonora Santini; Chiara Rossi; Paolo Miccoli; Ele Ferrannini; Anna Solini
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

Review 5.  Adipose Tissue-Derived Omentin-1 Function and Regulation.

Authors:  Takuya Watanabe; Kaho Watanabe-Kominato; Yui Takahashi; Miho Kojima; Rena Watanabe
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

6.  Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension.

Authors:  A de la Sierra; M Larrousse
Journal:  J Hum Hypertens       Date:  2009-11-26       Impact factor: 3.012

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Endothelium-dependent contractions and endothelial dysfunction in human hypertension.

Authors:  Daniele Versari; Elena Daghini; Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

9.  Fenofibrate increases serum vaspin by upregulating its expression in adipose tissue.

Authors:  Mingwei Chen; Datong Deng; Zhaohui Fang; Ming Xu; Honglin Hu; Li Luo; Youmin Wang
Journal:  Endocrine       Date:  2013-08-06       Impact factor: 3.633

10.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Authors:  G S Hotamisligil; P Arner; J F Caro; R L Atkinson; B M Spiegelman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  3 in total

1.  Analysis of alterations of serum inflammatory cytokines and fibrosis makers in patients with essential hypertension and left ventricular hypertrophy and the risk factors.

Authors:  Xia Li; Xiaofan Guo; Ye Chang; Naijin Zhang; Yingxian Sun
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Predictive Value of Apelin and Vaspin on Hemorrhagic Transformation in Patients with Acute Ischemic Stroke after Intravenous Thrombolysis and Analysis of Related Factors.

Authors:  Benju Zhu; Lili Yan; Haiyan Ren; Qiang Li; Xu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-18       Impact factor: 2.629

3.  Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients.

Authors:  Davide Bolignano; Evangelia Dounousi; Pierangela Presta; Marta Greco; Anila Duni; Giuseppina Crugliano; Charalambos Pappas; Ethymios Pappas; Francesco Dragone; Lampros Lakkas; Daniela Patrizia Foti; Michele Andreucci; Giuseppe Coppolino
Journal:  Clin Kidney J       Date:  2021-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.